Ultralife Q4 revenue $48.5M, but operating loss of $10.6M on $12.2M impairment; GAAP EPS ($0.45)

ULTRALIFE CORP

Revenue $48.5M (+10.6% YoY); operating loss ($10.6M) vs profit $1.5M last year, driven by $12.2M intangible asset impairment.
GAAP EPS ($0.45) includes ($0.57) impairment charge; adjusted EBITDA $5.7M (11.7% sales) vs $3.9M.
Battery & Energy sales $45.9M (+15.1% YoY); Communications Systems $2.6M (-35.2%).
Backlog $110.2M (+22% from Q3); management expects improved 2026 results.
Rebranding consolidates sub-brands under Ultralife; expects $1.4M tax credit under 45X.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.